Federal contract award
75A50324F80012
PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN))
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ASPR/ORM-SNS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79721D0166 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $13.9M |
| Current contract value | $13.9M |
| Potential contract value / ceiling | $69.4M |
| Start date | Sep 30, 2024 |
| Current end date | Sep 29, 2025 |
| Potential end date | Sep 29, 2025 |
| Latest award activity | Mar 27, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 27, 2026 | P00002 | $0 | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI MODIFICATION TO ADJUST END DATE DUE TO OPTIONS NOT EXERCISED. |
| Dec 3, 2024 | P00001 | $0 | PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN)) |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Terri Reed | Contact | terri.reed@hhs.gov 2027605886 | Source | Jun 5, 2024 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.